Article
Genetic variants in FKBP5 affecting response to antidepressant drug treatment.
Pharmacogenomics - 1 Jul 2008
Kirchheiner Julia, Lorch Rainer, Lebedeva Elena, Seeringer Angela, Roots Ivar, Sasse Johanna, Brockmöller Jürgen
Abstract excerpt
INTRODUCTION: Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is a pathogenic mechanism of depression, and genetic polymorphisms in HPA axis genes have been described to influence response to antidepressant drugs. In particular, two polymorphisms in FKBP5, a co-chaperone of the glucocorticoid receptor, were strongly associated with response to therapy. We aimed to analyze whether these findings...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
